This study is testing a medicine called avutometinib for children and young adults with serious solid tumor cancers. Solid tumors are lumps of cancer cells. The study aims to know if this medicine is safe and what dose is best without causing many side effects. You can join if you are between 3 and 30 years old, have a specific type of cancer, and meet certain health conditions. You must also be able to swallow pills and not be pregnant or breastfeeding.
- Participation Length: The study requires regular visits to the hospital for check-ups and tests.
- Eligibility: Must have a certain type of cancer and be in the age range of 3 to 30 years old.
- Risks: There might be side effects, and you need to stop certain medicines before joining.
Before joining, you or your parents will need to sign a consent form. The study will help doctors find out if avutometinib can be a safe treatment for these tough cancers. If you have questions, it’s best to talk to your doctor about whether this study is right for you.